| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0051 | 1 |